Verve Therapeutics's total assets for Q3 2023 were $612.41M, an increase of 3.95% from the previous quarter. VERV total liabilities were $152.04M for the fiscal quarter, a 22.70% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.